1Ueland, PM (2010) Choline and betaine in health and disease. J Inherit Metab Dis 34, 3–15.
2Zeisel, SH (2004) Nutritional importance of choline for brain development. J Am Coll Nutr 23, 621S–626S.
3Institute of Medicine (IOM) (1998) Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academies Press.
4Dudman, NP, Guo, XW, Gordon, RB, et al. (1996) Human homocysteine catabolism: three major pathways and their relevance to development of arterial occlusive disease. J Nutr 126, 1295S–1300S.
5Drouva, SV, LaPlante, E, Leblanc, P, et al. (1986) Estradiol activates methylating enzyme(s) involved in the conversion of phosphatidylethanolamine to phosphatidylcholine in rat pituitary membranes. Endocrinology 119, 2611–2622.
6Fischer, LM, daCosta, KA, Kwock, L, et al. (2007) Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr 85, 1275–1285.
7Fischer, LM, da Costa, KA, Kwock, L, et al. (2010) Dietary choline requirements of women: effects of estrogen and genetic variation. Am J Clin Nutr 92, 1113–1119.
8Holm, PI, Hustad, S, Ueland, PM, et al. (2007) Modulation of the homocysteine–betaine relationship by methylenetetrahydrofolate reductase 677 C → t genotypes and B-vitamin status in a large-scale epidemiological study. J Clin Endocrinol Metab 92, 1535–1541.
9Wald, DS, Law, M & Morris, JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 1202.
10Haan, MN, Miller, JW, Aiello, AE, et al. (2007) Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 85, 511–517.
11McLean, RR, Jacques, PF, Selhub, J, et al. (2008) Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women. J Clin Endocrinol Metab 93, 2206–2212.
12Kivipelto, M, Annerbo, S, Hultdin, J, et al. (2009) Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study. Eur J Neurol 16, 808–813.
13Kohaar, I, Kumar, J, Thakur, N, et al. (2010) Homocysteine levels are associated with cervical cancer independent of methylene tetrahydrofolate reductase gene (MTHFR) polymorphisms in Indian population. Biomarkers 15, 61–68.
14van den Kommer, TN, Dik, MG, Comijs, HC, et al. (2010) Homocysteine and inflammation: predictors of cognitive decline in older persons? Neurobiol Aging 31, 1700–1709.
15Marti-Carvajal, AJ, Sola, I, Lathyris, D, et al. (2009) Homocysteine lowering interventions for preventing cardiovascular events. The Cochrane Database Systematic Reviews, .
16Clarke, R, Halsey, J, Lewington, S, et al. (2010) Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 170, 1622–1631.
17Wang, X, Qin, X, Demirtas, H, et al. (2007) Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369, 1876–1882.
18Lee, M, Hong, KS, Chang, SC, et al. (2010) Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: a meta-analysis. Stroke 41, 1205–1212.
19Homocysteine Lowering Trialists’ Collaboration (2005) Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82, 806–812.
20Eussen, SJ, de Groot, LC, Clarke, R, et al. (2005) Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial. Arch Intern Med 165, 1167–1172.
21McKinley, MC, McNulty, H, McPartlin, J, et al. (2001) Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr 73, 759–764.
22McNulty, H, Dowey, LRC, Strain, JJ, et al. (2006) Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C → T polymorphism. Circulation 113, 74–80.
23Cho, E, Zeisel, SH, Jacques, P, et al. (2006) Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am J Clin Nutr 83, 905–911.
24Lee, JE, Jacques, PF, Dougherty, L, et al. (2010) Are dietary choline and betaine intakes determinants of total homocysteine concentration? Am J Clin Nutr 91, 1303–1310.
25Schwab, U, Torronen, A, Toppinen, L, et al. (2002) Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. Am J Clin Nutr 76, 961–967.
26Olthof, MR, van Vliet, T, Boelsma, E, et al. (2003) Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. J Nutr 133, 4135–4138.
27Atkinson, W, Slow, S, Elmslie, J, et al. (2009) Dietary and supplementary betaine: effects on betaine and homocysteine concentrations in males. Nutr Metab Cardiovasc Dis 19, 767–773.
28Price, RK, Keaveney, EM, Hamill, LL, et al. (2010) Consumption of wheat aleurone-rich foods increases fasting plasma betaine and modestly decreases fasting homocysteine and LDL-cholesterol in adults. J Nutr 140, 2153–2157.
29Olthof, MR, Brink, EJ, Katan, MB, et al. (2005) Choline supplemented as phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine concentrations in healthy men. Am J Clin Nutr 82, 111–117.
30Atkinson, W, Elmslie, J, Lever, M, et al. (2008) Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjects. Am J Clin Nutr 87, 577–585.
31Chiuve, SE, Giovannucci, EL, Hankinson, SE, et al. (2007) The association between betaine and choline intakes and the plasma concentrations of homocysteine in women. Am J Clin Nutr 86, 1073–1081.
32Dalmeijer, GW, Olthof, MR, Verhoef, P, et al. (2008) Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women. Eur J Clin Nutr 62, 386–394.
33Xu, X, Gammon, MD, Zeisel, SH, et al. (2009) High intakes of choline and betaine reduce breast cancer mortality in a population-based study. FASEB J 23, 4022–4028.
34Zeisel, SH, Da Costa, KA, Franklin, PD, et al. (1991) Choline, an essential nutrient for humans. FASEB J 5, 2093–2098.
35Wang, Z, Klipfell, E, Bennett, BJ, et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57–63.
36Olthof, MR, van Vliet, T, Verhoef, P, et al. (2005) Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans. PLoS Med 2, e135.
37Ward, M, McNulty, H, McPartlin, J, et al. (1997) Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM 90, 519–524.
38Holm, PI, Ueland, PM, Kvalheim, G, et al. (2003) Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography–tandem mass spectrometry. Clin Chem 49, 286–294.
39Molloy, AM & Scott, JM (1997) Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol 281, 43–53.
40Kelleher, BP & Broin, SD (1991) Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol 44, 592–595.
41Bates, CJ, Pentieva, KD, Matthews, N, et al. (1999) A simple, sensitive and reproducible assay for pyridoxal 5′-phosphate and 4-pyridoxic acid in human plasma. Clin Chim Acta 280, 101–111.
42Frosst, P, Blom, HJ, Milos, R, et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111–113.
43Powers, HJ, Bates, CJ, Prentice, AM, et al. (1983) The relative effectiveness of iron and iron with riboflavin in correcting a microcytic anaemia in men and children in rural Gambia. Hum Nutr Clin Nutr 37, 413–425.
44Friedewald, WT, Levy, RI & Fredrickson, DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502.
45Holm, PI, Ueland, PM, Vollset, SE, et al. (2005) Betaine and folate status as cooperative determinants of plasma homocysteine in humans. Arterioscler Thromb Vasc Biol 25, 379–385.
46Konstantinova, SV, Tell, GS, Vollset, SE, et al. (2008) Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr 138, 914–920.
47Veenema, K, Solis, C, Li, R, et al. (2008) Adequate intake levels of choline are sufficient for preventing elevations in serum markers of liver dysfunction in Mexican American men but are not optimal for minimizing plasma total homocysteine increases after a methionine load. Am J Clin Nutr 88, 685–692.
48Melse-Boonstra, A, Holm, PI, Ueland, PM, et al. (2005) Betaine concentration as a determinant of fasting total homocysteine concentrations and the effect of folic acid supplementation on betaine concentrations. Am J Clin Nutr 81, 1378–1382.
49Hoey, L, McNulty, H, Askin, N, et al. (2007) Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults. Am J Clin Nutr 86, 1405–1413.
50USDA (2008) US Department of Agriculture Database for the Choline Content of Common Foods. Release Two. Beltsville, MD: US Department of Agriculture.
51Ueland, PM, Holm, PI & Hustad, S (2005) Betaine: a key modulator of one-carbon metabolism and homocysteine status. Clin Chem Lab Med 43, 1069–1075.
52Xu, X, Gammon, MD, Zeisel, SH, et al. (2008) Choline metabolism and risk of breast cancer in a population-based study. FASEB J 22, 2045–2052.
53Bjelland, I, Tell, GS, Vollset, SE, et al. (2009) Choline in anxiety and depression: the Hordaland Health Study. Am J Clin Nutr 90, 1056–1060.
54Rak, K & Rader, DJ (2011) Cardiovascular disease: the diet–microbe morbid union. Nature 472, 40–41.